Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
17 participants
OBSERVATIONAL
2025-04-07
2025-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Research question: The aim of this qualitative study is to get a better understanding of role of SDM in the choice of telemonitoring or standard care. These insights could help to offer improvements to SDM in IBD care to patients. This led to the following research questions:
1\. How to optimize the decision-making process for patients with inflammatory bowel disease in the decision for telemonitoring? 1.1 How do patients and healthcare professionals perceive the current SDM within care processes for IBD?
Study design: This is a qualitative study using semi-structured interviews. Information about patient's and professionals' experiences and preferences about SDM will be collected. To guide the topics in the interview, two theories/models will be used:
1. The Three-Talk Model
2. AAMC Telehealth Competencies Data will be analysed using thematic analysis.
Study population: Consecutive adult (≥18 years) IBD patients and IBD healthcare professionals at Jeroen Bosch Hospital and Franciscus who have experienced making a choice about telemonitoring will be asked if they are willing to participate. Next, a total of 16 respondents will be include 10 patients and 6 healthcare professionals. Both patients using telemonitoring and patients who are not interested will be included. Should data saturation not have occurred, more respondents will be included.
Expected results and relevance: The objective is to investigates if and how SDM is currently integrated into the telemonitoring processes for IBD patients. The goal is to use these insights to strengthen SDM in the decision for telemonitoring for IBD patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Digital Treatment of Irritable Bowel Syndrome (IBS)
NCT06117865
Digital Behavioral Interventions in Inflammatory Bowel Disease
NCT04861597
Donor Selection for Faecal Microbiota Transplantation in Irritable Bowel Syndrome
NCT06171126
Effectiveness of Internet Delivered Cognitive Behavior Therapy (CBT) for Irritable Bowel Syndrome (IBS)
NCT00844961
Fecal Microbiota Transplantation in Irritable Bowel Syndrome With Bloating
NCT02299973
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthcare providers
Interviews with healthcare providers
Interview
Interview
Patients
Interviews with patiens
Interview
Interview
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interview
Interview
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Confirmed IBD diagnosis
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jeroen Bosch Ziekenhuis
OTHER
Franciscus Gasthuis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tessa EH Römkens, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Jeroen Bosch Ziekenhuis
Rachel L West, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Franciscus Gasthuis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, , Netherlands
Franciscus
Rotterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025.03.09.01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.